content top

Neuroradiology Series: Brain Tumors


08:30 AM – 12:00 PM


Daniel Paul Barboriak, MD, and Aaron Scott Field, MD, PhD

Code: VN21


This session has 13 sections. First is Perfusion and Permeability Methods, while the second is Evaluation of Brain Tumor Response to Novel Treatments: What You Need to Know. Third section is The Utility of Multimodality Magnetic Resonance Imaging in the Differentiation of Primary CNS Lymphoma and High Grade . The section number four is Quantitative Evaluation of Perfusion and Permeability in High-Grade Gliomas: Dynamic Contrast-enhanced MR Imaging in 3D at 3 T. Fifth section is Glioma Grading: Automated Classifier Using Cerebral Perfusion, MR Spectroscopy, and Visual Grading, while the sixth is Progressive Tumor vs. Treatment Necrosis in Enhancing Brain Lesions: A Comparison of Dynamic Susceptibility Contrast (DSC) Perfusion and FDG PET/CT with Pathologic Correlation.

Seventh section is Diffusion-Tensor Imaging, while the eighth is Integrated Preoperative Brain Mapping: Cases and Concepts. Ninth section is Glioma Grading: Comparison of Parameters from Dynamic Contrast-enhanced (DCE) MRI, Apparent Diffusion Coefficient (ADC), and Fractional Anisotropy (FA). The tenth section is Neurosurgical “Golden Rule” for Brain Tumors in the Era of Modern Neuronavigational Stereotactic Neurosurgery and Functional MR Imaging: Relevance and Redefinition. Eleventh is Evaluation of Tracer Kinetic Parameters in Brain Gliomas Using T1W and T2*W contrast-enhanced Dynamic MR Imaging: Comparison with Pathological Findings. The twelfth section is DSC MR Perfusion Analysis of Pseudoprogression versus True Tumoral Progression in Gliomas, while thirteenth is Expert Panel Q&A.


Leave a Reply